American journal of obstetrics and gynecology
-
Our objective was to determine the normal sequence of neurobehavioral development in the human fetus between 14 weeks' gestation and delivery. ⋯ During the first half of the midtrimester there was a high rate of spontaneous movement that appeared randomly distributed. By the end of that trimester an increase in the duration of intervals of quiescence resulted in activity appearing cyclically distributed, with the duration of quiet cycles progressively increasing to term. Fetal mouthing and breathing were linked with cyclic behavior from the time of their emergence. Fetal heart rate pattern A could be recognized from around 32 weeks, due to a reduction in baseline variability in quiet cycles after 30 weeks, whereas pattern B could be recognized several weeks earlier. From the time cyclic behavior and heart rate patterns could be recognized, intervals of coincidence of the fetal behavioral state variables increased progressively with advancing gestation.
-
Am. J. Obstet. Gynecol. · Apr 1992
Leadership qualities of obstetrics and gynecology department chairmen of United States medical schools.
The purpose of this study is to examine leadership qualities, preparation for leadership, and perceptions of skills needed for academic leaders in obstetrics and gynecology. ⋯ Current academic leaders in obstetrics and gynecology must identify and prepare protégés (protégées) for future leadership roles.
-
Am. J. Obstet. Gynecol. · Mar 1992
Case ReportsLatex anaphylaxis in an obstetrics and gynecology physician.
Latex anaphylaxis caused by surgical gloves developed in a physician with a history of urticaria to latex. Standard therapy with epinephrine and fluids was effective. Latex allergy should be included in the differential diagnosis for anaphylaxis in a patient or a physician.
-
Am. J. Obstet. Gynecol. · Feb 1992
ReviewTreatment of uterine fibroids: current findings with gonadotropin-releasing hormone agonists.
The gonadotropin-releasing hormone agonists have potential benefit as presurgical adjuncts in the management of uterine leiomyomas or fibroids. Uterine fibroids contain estrogen receptors and are responsive to therapeutic hormonal manipulation; gonadotropin-releasing hormone agonists are effective by inducing a state of hypoestrogenism. ⋯ The advantages of the preoperative use of gonadotropin-releasing hormone agonists include a reduction in uterine and myoma size and vascularity and potentially improved operative technique and uterine cavity integrity. Ongoing clinical trials will be needed to confirm the role of gonadotropin-releasing hormone agonists in the treatment of uterine fibroids.